Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Hutter

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
Blood|June 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaSascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Oncotarget|September 18, 2015
Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older ageAdam M Fontebasso, Margret Shirinian, Dong-Anh Khuong-Quang, et al.
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
Blood|June 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaSascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, et al.
NPJ Precision Oncology|October 26, 2023
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncologyAndreas Mock, Maria-Veronica Teleanu, Simon Kreutzfeldt, et al.
Med (New York, N.Y.)|May 1, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasmsSimon Kreutzfeldt, Leonidas Apostolidis, Małgorzata Oleś, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Oncotarget|September 18, 2015
Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older ageAdam M Fontebasso, Margret Shirinian, Dong-Anh Khuong-Quang, et al.
Nature Communications|April 11, 2019
Defective homologous recombination DNA repair as therapeutic target in advanced chordomaStefan Gröschel, Daniel Hübschmann, Francesco Raimondi, et al.
Cancer Discovery|May 27, 2018
<i>NRG1</i> Fusions in <i>KRAS</i> Wild-Type Pancreatic CancerChristoph Heining, Peter Horak, Sebastian Uhrig, et al.
Nature Communications|January 12, 2018
Integrative genomic and transcriptomic analysis of leiomyosarcomaPriya Chudasama, Sadaf S Mughal, Mathijs A Sanders, et al.
Nature Communications|August 2, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneityLino Möhrmann, Maximilian Werner, Małgorzata Oleś, et al.
Pageof 7